CANAGLIFLOZIN\METFORMIN: 1,544 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,544
Total FAERS Reports
27 (1.7%)
Deaths Reported
615
Hospitalizations
1,544
As Primary/Secondary Suspect
44
Life-Threatening
81
Disabilities
Active Ingredient: CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE ·
First Report: 2000 · Latest Report: 20250614
What Are the Most Common CANAGLIFLOZIN\METFORMIN Side Effects?
#1 Most Reported
Osteomyelitis
197 reports (12.8%)
#2 Most Reported
Toe amputation
196 reports (12.7%)
#3 Most Reported
Diabetic ketoacidosis
185 reports (12.0%)
All CANAGLIFLOZIN\METFORMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Osteomyelitis | 197 | 12.8% | 2 | 167 |
| Toe amputation | 196 | 12.7% | 2 | 145 |
| Diabetic ketoacidosis | 185 | 12.0% | 1 | 173 |
| Acute kidney injury | 105 | 6.8% | 2 | 98 |
| Cellulitis | 92 | 6.0% | 2 | 83 |
| Diabetic foot infection | 85 | 5.5% | 0 | 79 |
| Gangrene | 82 | 5.3% | 0 | 76 |
| Blood glucose increased | 69 | 4.5% | 0 | 6 |
| Off label use | 67 | 4.3% | 0 | 13 |
| Diabetic foot | 65 | 4.2% | 0 | 57 |
| Leg amputation | 62 | 4.0% | 1 | 58 |
| Foot amputation | 59 | 3.8% | 0 | 55 |
| Weight decreased | 58 | 3.8% | 0 | 4 |
| Nausea | 57 | 3.7% | 0 | 17 |
| Inappropriate schedule of drug administration | 56 | 3.6% | 0 | 3 |
| Fungal infection | 53 | 3.4% | 0 | 3 |
| Diarrhoea | 51 | 3.3% | 0 | 6 |
| Skin ulcer | 51 | 3.3% | 1 | 39 |
| Drug prescribing error | 43 | 2.8% | 0 | 2 |
| Sepsis | 42 | 2.7% | 0 | 42 |
Who Reports CANAGLIFLOZIN\METFORMIN Side Effects? Age & Gender Data
Gender: 49.6% female, 50.4% male. Average age: 57.7 years. Most reports from: US. View detailed demographics →
Is CANAGLIFLOZIN\METFORMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 0 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 0 |
| 2013 | 5 | 0 | 3 |
| 2014 | 51 | 1 | 26 |
| 2015 | 288 | 1 | 156 |
| 2016 | 260 | 3 | 144 |
| 2017 | 171 | 1 | 111 |
| 2018 | 79 | 6 | 52 |
| 2019 | 25 | 2 | 11 |
| 2020 | 6 | 0 | 2 |
| 2021 | 10 | 1 | 4 |
| 2022 | 6 | 0 | 4 |
| 2023 | 5 | 0 | 1 |
| 2024 | 10 | 0 | 9 |
| 2025 | 3 | 0 | 2 |
What Is CANAGLIFLOZIN\METFORMIN Used For?
CANAGLIFLOZIN\METFORMIN vs Alternatives: Which Is Safer?
CANAGLIFLOZIN\METFORMIN vs CANAKINUMAB
CANAGLIFLOZIN\METFORMIN vs CANDESARTAN
CANAGLIFLOZIN\METFORMIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN\METFORMIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAGLIFLOZIN\METFORMIN vs CANGRELOR
CANAGLIFLOZIN\METFORMIN vs CANIS LUPUS FAMILIARIS SKIN
CANAGLIFLOZIN\METFORMIN vs CANNABIDIOL
CANAGLIFLOZIN\METFORMIN vs CANNABIDIOL\HERBALS
CANAGLIFLOZIN\METFORMIN vs CANNABIS SATIVA FLOWERING TOP
CANAGLIFLOZIN\METFORMIN vs CANNABIS SATIVA SUBSP. INDICA TOP
Official FDA Label for CANAGLIFLOZIN\METFORMIN
Official prescribing information from the FDA-approved drug label.